RACHEL KRUMRIE: Open Payments
NPI 1013542018 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 14 payments from 10 companies in 2025. Trend: 2023 $1,525 · 2024 $77 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 2 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Boston Scientific Corporation | 1 | $17 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $15 |
Products named: Tyvaso, JARDIANCE, WINREVAIR, Adempas, SHINGRIX, Attruby, LEQVIO, Kerendia.
Industry payments across TN — which companies pay providers there.
